The use of activated factor VII for ventricular septal defect closure in a pediatric patient with hemophilia A and a high titer of inhibitor.
de Souza
Duncan G
DG
Department of Anesthesiology, University of Virginia, Charlottesville, VA 22908-0710, USA. dgd6n@virginia.edu
Waldron
Peter E
PE
Peeler
Benjamin B
BB
Baum
Victor C
VC
D019774:Blood Coagulation Factor Inhibitors / Q000096:biosynthesis / Q000097:blood*; D015941:Complement Hemolytic Activity Assay; D015942:Factor VIIa / Q000627:therapeutic use*; D006345:Heart Septal Defects, Ventricular / Q000097:blood / Q000150:complications / Q000188:drug therapy*; D006467:Hemophilia A / Q000097:blood / Q000150:complications / Q000188:drug therapy*; D006801:Humans; D007223:Infant; D008297:Male
D019774:Blood Coagulation Factor Inhibitors; D015942:Factor VIIa